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Abstract
We report for the first time in Jordan and probably Arab countries a 
very rare case of Comamonas testosteroni causing blood stream infec-
tion in a Sudanese patient with renal failure on hemodialysis whom 
was waiting for a living-related renal transplant. He was successfully 
treated with cefepime and had his transplant ten days into his treat-
ment. Post-transplant he did well and was discharged home.
Keywords: Comamonas testosteroni, Renal failure, kidney transplant, 
cefepime, blood stream infection
Introduction
Comamonas testosterone (formerly Pseudomonas testosteroni) is a 
ubiquitous aerobic gram-negative bacillus, motile, glucose non-fermen-
ter, do not form spores. It is found in soil, plants, water saprophytes, 
and also may be found in humidifier reservoir water, even isolated 
from dromedary rumen fluid (1). Although it is frequently considered a 
commensal, it is a potential human pathogen. Attention was drawn to 
Comamonas testosteroni since1987 when reports were accumulating 
on human infections at different sites, such as cellulitis (2), peritonitis 
especially with a perforated appendix (3), bloodstream infection (4,5), 
infective endocarditis (6), purulent meningitis, (7) postoperative en-
dophthalmitis (8) and hemodialysis catheter-related bacteremia (9). It 
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may express a putative protein that exhibits similar-
ity to Pasteurella multocida (10). Furthermore, some 
strains of Comamonas testosteroni acquired plasmid 
mediated blaNDM1, hampering treatment options 
in the event this bacterium causes human infec-
tions (11). An interesting finding is that a related 
species i.e. Comamonas acidovorans isolated from 
water pond in South Jordan was found to have an 
antifungal activity against filamentous fungi and 
yeasts (12).
The Case
A 47 year old male patient from Sudan, he suffered 
from end-stage renal disease and maintained on 
hemodialysis for the last three months through a 
subclavian central venous catheter before he pre-
sented to us. He presented to outpatient clinic for 
assessment as a kidney transplant candidate. He 
had been having chills during dialysis session, but 
no documented fever. Two sets of blood cultures 
including aerobic and anaerobic bottles grew Co-
mamonas testosteroni. Patient hemodialysis cath-
eter (PermaCath) was removed and replaced with 
a temporary central venous hemodialysis catheter. 
He was treated with parenteral cefepime (one gram 
daily for 14 days). Day 4 on treatment, blood cul-
ture was sterile. The patients was transplanted from 
a living-related Kidney donor, meanwhile he was 
on cefepime without complications. He was main-
tained on oral cyclosporine 200mg twice daily, My-
cophenolate mofetil 360mg twice daily by mouth 
and prednisone 30mg by mouth twice daily. Also, 
he was started on oral INH 300mg once daily.
Culture and Identification of Comamonas 
testosteroni
Patients’ Blood samples were inoculated into blood 
culture bottles (BD BACTEC Aerobic/F, Shannon , 
Ireland ). One droplet of the positive growth blood 
culture was inoculate into BD BACTEC 9120 Blood 
culture system (Becton, Dickinson and company 
Franklin Lakes, NJ, USA) was placed on sheep 
blood agar, chocolate blood agar and Maconkey 
agar plates (Oxoid Diagnostic Company Ltd, Bas-
ingstoke, Hampshire, England) and pricked by ster-
ile needle. Chocolate-agar plates were incubated in 
micro-aerophilic conditions prepared by a candle jar 
at 37C0. Sheep blood agar plates and MacConkey 
agar plates were aerobically incubated at 37C0 for 
24-48 hours. Gram-negative bacterial colonies ap-
peared on blood, chocolate, and MacConkey agar 
after 24 hours of incubation. Gram staining was 
performed for both single colonies and patient’s 
blood sample showed gram-negative bacilli. The 
isolate was catalase negative and oxidase positive. 
The complementary identical tests were performed 
using biochemical test (Vitek 2 system, Biomerieux, 
France, Europe).
Antimicrobials susceptibility tests were performed 
based on Kirby-Bauer disk-diffusion method on 
Mueller-Hinton agar plates, antibiotic disk (OXOID 
Company,England), double-checked by MIC method 
using Vitek II system (Biomerieux, France, Europe). 
Finally, this strain was identified as Comamonas 
testosterone with high certainty. The isolated or-
ganism was sensitive to cefepime, ciprofloxacin, co-
trimoxzole, levofloxacin, ofloxacin, polymyxin B and 
tigecycline, and was resistant to amikacin, gentami-
cin, Imipenem, meropenem, and pipracillin/tazobac-
tam with intermediate sensitivity for ceftazidime.
Discussion
Comamonas testosterone has been reported infre-
quently as a cause of different infections. It was 
given this name due to its characteristic of utilizing 
carbon from the metabolism of testosterone (13). 
Main points worth consideration is that most in-
fections took place in community, rarely occurring 
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in nosocomial setting (8), and that most reported 
patients have somehow immune suppression such 
as malignancy (4), on hemodialysis patients, (9) al-
coholic patient, patient with hepatitis B infection 
with liver cirrhosis and hepatocellular carcinoma (2), 
and cholesteatoma (7). This patient has end-stage 
renal disease, possibly got the infection while he is 
under outpatient medical care on hemodialysis i.e. 
healthcare-associated infection, like few previously 
reported cases.
Comamonas testosteroni treatment is reported 
mostly utilizing cephalosporins including cefepime, 
cefoxitine, ceftazidime, ciprofloxacin, imipenem, 
meropenem and ampicillin once susceptible (4). One 
case of meningitis was reported to have had failed 
on ceftriaxone treatment though was in vitro sus-
ceptible, the patient was switched to meropenem 
with response (7).
This case report was treated with parenteral ce-
fepime one gram daily with success, adjusted for 
renal failure before and after kidney transplantation. 
He was successfully transplanted with a kidney from 
a living-related donor and was discharged home on 
immunosuppressive therapy in good health condi-
tion. 
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